Contact

All Stories

  1. Impact of blood component transfusions, tranexamic acid and fluids on subarachnoid hemorrhage outcomes

    Article • Brain Hemorrhages, June 2023, Tsinghua University Press

    Sylvain Dore

  2. Effects of Sound Interventions on the Permeability of the Blood–Brain Barrier and Meningeal Lymphatic Clearance

    Article • Brain Sciences, June 2022, MDPI AG

    Sylvain Dore

  3. Role of CRF and the hypothalamic‐pituitary‐adrenal axis in stroke: revisiting temporal considerations and targeting a new generation of therapeutics

    Article • FEBS Journal, February 2022, Wiley

    Sylvain Dore

  4. Influence of Haptoglobin Polymorphism on Stroke in Sickle Cell Disease Patients

    Article • Genes, January 2022, MDPI AG

    Sylvain Dore

  5. Genome-Wide Association Study of Clinical Outcome After Aneurysmal Subarachnoid Haemorrhage: Protocol

    Article • Translational Stroke Research, January 2022, Springer Science + Business Media

    Sylvain Dore

  6. Potential Role of Soluble Toll-like Receptors 2 and 4 as Therapeutic Agents in Stroke and Brain Hemorrhage

    Article • International Journal of Molecular Sciences, September 2021, MDPI AG

    Sylvain Dore

  7. Cerebral Venous Thrombosis and Hypercoagulability Associated With In Vitro Fertilization

    Article • Stroke, September 2021, Wolters Kluwer Health

    Sylvain Dore

  8. Association of Serum Bilirubin with the Severity and Outcomes of Intracerebral Hemorrhages

    Article • Antioxidants, August 2021, MDPI AG

    Sylvain Dore

  9. Carbon Monoxide Therapy Using Hybrid Carbon Monoxide-Releasing/Nrf2-Inducing Molecules through a Neuroprotective Lens

    Article • Chemistry, July 2021, MDPI AG

    Sylvain Dore

  10. Critical Role of Hemopexin Mediated Cytoprotection in the Pathophysiology of Sickle Cell Disease

    Article • International Journal of Molecular Sciences, June 2021, MDPI AG

    Sylvain Dore

  11. Nrf2 as a therapeutic target in ischemic stroke

    Article • Expert Opinion on Therapeutic Targets, March 2021, Taylor & Francis

    Sylvain Dore

  12. Haptoglobin Genotype Affects Inflammation after Aneurysmal Subarachnoid Hemorrhage

    Article • Current Neurovascular Research, February 2021, Bentham Science Publishers

    Sylvain Dore, Devin McBride

  13. Soluble Receptors Affecting Stroke Outcomes: Potential Biomarkers and Therapeutic Tools

    Article • International Journal of Molecular Sciences, January 2021, MDPI AG

    Sylvain Dore

  14. Effect of Experimental Ischemic Stroke and PGE2 EP1 Selective Antagonism in Alzheimer’s Disease Mouse Models

    Article • Journal of Alzheimer’s Disease, March 2020, IOS Press

    Sylvain Dore

  15. Distinctive effect of anesthetics on the effect of limb remote ischemic postconditioning following ischemic stroke

    Article • PLoS ONE, January 2020, PLOS

    Sylvain Dore

  16. Role of the PGE 2 receptor subtypes EP1, EP2, and EP3 in repetitive traumatic brain injury

    Article • CNS Neuroscience & Therapeutics, October 2019, Wiley

    Sylvain Dore

  17. Blood-Related Toxicity after Traumatic Brain Injury: Potential Targets for Neuroprotection

    Article • Molecular Neurobiology, October 2019, Springer Science + Business Media

    Sylvain Dore

  18. Reactive Gliosis Contributes to Nrf2-Dependent Neuroprotection by Pretreatment with Dimethyl Fumarate or Korean Red Ginseng Against Hypoxic-Ischemia: Focus on Hippocampal Injury

    Article • Molecular Neurobiology, September 2019, Springer Science + Business Media

    Sylvain Dore

  19. Nrf2 Plays an Essential Role in Long-Term Brain Damage and Neuroprotection of Korean Red Ginseng in a Permanent Cerebral Ischemia Model

    Article • Antioxidants, August 2019, MDPI AG

    Sylvain Dore

  20. Haptoglobin genotype and aneurysmal subarachnoid hemorrhage

    Article • Neurology, April 2019, Wolters Kluwer Health

    Diederik Bulters, Sylvain Dore

  21. Pretreatment with Korean red ginseng or dimethyl fumarate attenuates reactive gliosis and confers sustained neuroprotection against cerebral hypoxic-ischemic damage by an Nrf2-dependent mechanism

    Article • Free Radical Biology and Medicine, February 2019, Elsevier

    Sylvain Dore

  22. Bilirubin and Ischemic Stroke: Rendering the Current Paradigm to Better Understand the Protective Effects of Bilirubin

    Article • Molecular Neurobiology, January 2019, Springer Science + Business Media

    Sylvain Dore

  23. Unique Properties Associated with the Brain Penetrant Iron Chelator HBED Reveal Remarkable Beneficial Effects after Brain Trauma

    Article • Journal of Neurotrauma, January 2019, Mary Ann Liebert Inc

    Sylvain Dore

  24. Genetic Deletion of PGF2α-FP Receptor Exacerbates Brain Injury Following Experimental Intracerebral Hemorrhage

    Article • Frontiers in Neuroscience, September 2018, Frontiers

    Sylvain Dore

  25. Haemoglobin scavenging in intracranial bleeding: biology and clinical implications

    Article • Nature Reviews Neurology, June 2018, Springer Science + Business Media

    Diederik Bulters, Sylvain Dore

  26. A Pilot Study of Inhaled CO Therapy in Neonatal Hypoxia-Ischemia: Carboxyhemoglobin Concentrations and Brain Volumes

    Article • Frontiers in Pediatrics, May 2018, Frontiers

    Sylvain Dore

  27. Korean Red Ginseng Pretreatment Protects Against Long-Term Sensorimotor Deficits After Ischemic Stroke Likely Through Nrf2

    Article • Frontiers in Cellular Neuroscience, March 2018, Frontiers

    Sylvain Dore

  28. A Comparison of Pathophysiology in Humans and Rodent Models of Subarachnoid Hemorrhage

    Article • Frontiers in Molecular Neuroscience, March 2018, Frontiers

    Sylvain Dore

  29. Local Delivery Is Critical for Monocyte Chemotactic Protein-1 Mediated Site-Specific Murine Aneurysm Healing

    Article • Frontiers in Neurology, March 2018, Frontiers

    Sylvain Dore

  30. Limb Remote Ischemic Conditioning: Mechanisms, Anesthetics, and the Potential for Expanding Therapeutic Options

    Article • Frontiers in Neurology, February 2018, Frontiers

    Sylvain Dore

  31. Efficacy of Laropiprant in Minimizing Brain Injury Following Experimental Intracerebral Hemorrhage

    Article • Scientific Reports, August 2017, Springer Science + Business Media

    Sylvain Dore

  32. Role of Interleukin-10 in Acute Brain Injuries

    Article • Frontiers in Neurology, June 2017, Frontiers

    Dr Nancy J Edwards, Sylvain Dore

  33. The absence of the CD163 receptor has distinct temporal influences on intracerebral hemorrhage outcomes

    Article • Journal of Cerebral Blood Flow & Metabolism, March 2017, SAGE Publications

    Sylvain Dore

  34. Age-Dependent Effects of Haptoglobin Deletion in Neurobehavioral and Anatomical Outcomes Following Traumatic Brain Injury

    Article • Frontiers in Molecular Biosciences, July 2016, Frontiers

    Sylvain Dore

  35. PGE2-EP3 signaling exacerbates intracerebral hemorrhage outcomes in 24-mo-old mice

    Article • AJP Heart and Circulatory Physiology, June 2016, American Physiological Society

    Sylvain Dore

  36. Deletion of the hemopexin or heme oxygenase-2 gene aggravates brain injury following stroma-free hemoglobin-induced intracerebral hemorrhage

    Article • Journal of Neuroinflammation, February 2016, Springer Science + Business Media

    Sylvain Dore

  37. Increased brain hemopexin levels improve outcomes after intracerebral hemorrhage

    Article • Journal of Cerebral Blood Flow & Metabolism, January 2016, SAGE Publications

    Sylvain Dore

  38. Animal Models of Posttraumatic Seizures and Epilepsy

    Article • January 2016, Springer Science + Business Media

    Sylvain Dore

  39. Detrimental role of the EP1 prostanoid receptor in blood-brain barrier damage following experimental ischemic stroke

    Article • Scientific Reports, December 2015, Springer Science + Business Media

    Sylvain Dore

  40. Considerations for the Optimization of Induced White Matter Injury Preclinical Models

    Article • Frontiers in Neurology, August 2015, Frontiers

    Sylvain Dore

  41. Intracerebral hemorrhage outcomes following selective blockade or stimulation of the PGE2 EP1 receptor

    Article • BMC Neuroscience, August 2015, Springer Science + Business Media

    Sylvain Dore

  42. Neuroprotective effert of carbon monoxide and Nrf2 in cerebral ischemia

    Article • SpringerPlus, June 2015, Springer Science + Business Media

    Sylvain Dore

  43. Genetic deletion of the prostaglandin E2E prostanoid receptor subtype 3 improves anatomical and functional outcomes after intracerebral hemorrhage

    Article • European Journal of Neuroscience, May 2015, Wiley

    Sylvain Dore

  44. Prostaglandin E2 EP2 Receptor Deletion Attenuates Intracerebral Hemorrhage-Induced Brain Injury and Improves Functional Recovery

    Article • ASN NEURO, April 2015, SAGE Publications

    Sylvain Dore

  45. Efficacy of prophylactic flavan-3-ol in permanent focal ischemia in 12-mo-old mice

    Article • AJP Heart and Circulatory Physiology, March 2015, American Physiological Society

    Sylvain Dore

  46. Ginseng: a promising neuroprotective strategy in stroke

    Article • Frontiers in Cellular Neuroscience, January 2015, Frontiers

    Sylvain Dore

  47. Haptoglobin phenotype predicts the development of focal and global cerebral vasospasm and may influence outcomes after aneurysmal subarachnoid hemorrhage

    Article • Proceedings of the National Academy of Sciences, January 2015, Proceedings of the National Academy of Sciences

    Sylvain Dore

  48. Neuroprotective role of prostaglandin PGE2 EP2 receptor in hemin-mediated toxicity

    Article • NeuroToxicology, January 2015, Elsevier

    Sylvain Dore

  49. Role of the Prostaglandin E2 EP1 Receptor in Traumatic Brain Injury

    Article • PLoS ONE, November 2014, PLOS

    Sylvain Dore

  50. Endothelin-1-mediated vasoconstriction alters cerebral gene expression in iron homeostasis and eicosanoid metabolism

    Article • Brain Research, November 2014, Elsevier

    Sylvain Dore

  51. Heme–Hemopexin Complex Attenuates Neuronal Cell Death and Stroke Damage

    Article • Journal of Cerebral Blood Flow & Metabolism, April 2014, SAGE Publications

    Sylvain Dore

  52. The Flavanol (−)-Epicatechin Prevents Stroke Damage through the Nrf2/HO1 Pathway

    Article • Journal of Cerebral Blood Flow & Metabolism, April 2014, SAGE Publications

    Sylvain Dore

  53. Neurovascular protection by post‐ischemic intravenous injections of the lipoxin A 4 receptor agonist, BML ‐111, in a rat model of ischemic stroke

    Article • Journal of Neurochemistry, December 2013, Wiley

    Sylvain Dore

  54. Prostaglandin F2α FP receptor antagonist improves outcomes after experimental traumatic brain injury

    Article • Journal of Neuroinflammation, October 2013, Springer Science + Business Media

    Sylvain Dore

  55. Oral administration of the flavanol (−)-epicatechin bolsters endogenous protection against focal ischemia through the Nrf2 cytoprotective pathway

    Article • European Journal of Neuroscience, September 2013, Wiley

    Sylvain Dore

  56. Cathepsin G-Dependent Modulation of Platelet Thrombus Formation In Vivo by Blood Neutrophils

    Article • PLoS ONE, August 2013, PLOS

    Sylvain Dore

  57. Role of PGE2 EP1 Receptor in Intracerebral Hemorrhage-Induced Brain Injury

    Article • Neurotoxicity Research, July 2013, Springer Science + Business Media

    Sylvain Dore

  58. Neuroprotective Properties and Mechanisms of Resveratrol in in Vitro and in Vivo Experimental Cerebral Stroke Models

    Article • ACS Chemical Neuroscience, June 2013, American Chemical Society (ACS)

    Sylvain Dore

  59. PGE2 EP1 Receptor Deletion Attenuates 6-OHDA-Induced Parkinsonism in Mice: Old Switch, New Target

    Article • Neurotoxicity Research, February 2013, Springer Science + Business Media

    Sylvain Dore

  60. Contribution of PGE2 EP1 receptor in hemin-induced neurotoxicity

    Article • Frontiers in Molecular Neuroscience, January 2013, Frontiers

    Sylvain Dore

  61. Effect of temperature on CO sensing response in air ambient by using ZnO nanorod-gated AlGaN/GaN high electron mobility transistors

    Article • Sensors and Actuators B Chemical, January 2013, Elsevier

    Sylvain Dore

  62. Prostaglandin FP receptor inhibitor reduces ischemic brain damage and neurotoxicity

    Article • Neurobiology of Disease, October 2012, Elsevier

    Sylvain Dore

  63. PGE2 EP1 receptor exacerbated neurotoxicity in a mouse model of cerebral ischemia and Alzheimer's disease

    Article • Neurobiology of Aging, September 2012, Elsevier

    Sylvain Dore

  64. Histone deacetylase inhibition activates transcription factor Nrf2 and protects against cerebral ischemic damage

    Article • Free Radical Biology and Medicine, March 2012, Elsevier

    Sylvain Dore

  65. Putative Role of Prostaglandin Receptor in Intracerebral Hemorrhage

    Article • Frontiers in Neurology, January 2012, Frontiers

    Sylvain Dore

  66. Carbon monoxide detection sensitivity of ZnO nanorod-gated AlGaN/GaN high electron mobility transistors in different temperature environments

    Article • Journal of Vacuum Science & Technology B Nanotechnology and Microelectronics Materials Processing Measurement and Phenomena, January 2012, American Vacuum Society

    Sylvain Dore

  67. Translating Basic Science Research to Clinical Application: Models and Strategies for Intracerebral Hemorrhage

    Article • Frontiers in Neurology, January 2012, Frontiers

    Sylvain Dore

  68. Effect of temperature on CO detection sensitivity of ZnO nanorod-gated AlGaN/GaN high electron mobility transistors

    Article • Applied Physics Letters, October 2011, American Institute of Physics

    Sylvain Dore

  69. Carbon Monoxide–Activated Nrf2 Pathway Leads to Protection Against Permanent Focal Cerebral Ischemia

    Article • Stroke, September 2011, Wolters Kluwer Health

    Sylvain Dore

  70. Dietary flavonoids are neuroprotective through Nrf2-coordinated induction of endogenous cytoprotective proteins

    Article • Nutritional Neuroscience, September 2011, Taylor & Francis

    Sylvain Dore

  71. Heme oxygenase 1, beneficial role in permanent ischemic stroke and in Gingko biloba (EGb 761) neuroprotection

    Article • Neuroscience, April 2011, Elsevier

    Sylvain Dore

  72. Fenoldopam Preconditioning: Role of Heme Oxygenase-1 in Protecting Human Tubular Cells and Rodent Kidneys Against Cold-Hypoxic Injury

    Article • Transplantation, January 2011, Wolters Kluwer Health

    Sylvain Dore

  73. Myelin-associated glycoprotein protects neurons from excitotoxicity

    Article • Journal of Neurochemistry, January 2011, Wiley

    Sylvain Dore

  74. Neuroprotective properties of prostaglandin I2 IP receptor in focal cerebral ischemia

    Article • Neuroscience, September 2010, Elsevier

    Sylvain Dore

  75. Cytosolic phospholipase A2alpha amplifies early cyclooxygenase-2 expression, oxidative stress and MAP kinase phosphorylation after cerebral ischemia in mice

    Article • Journal of Neuroinflammation, July 2010, Springer Science + Business Media

    Sylvain Dore

  76. The PGE2 EP2 receptor and its selective activation are beneficial against ischemic stroke

    Article • Experimental & Translational Stroke Medicine, July 2010, Springer Science + Business Media

    Sylvain Dore

  77. Resveratrol protects against experimental stroke: Putative neuroprotective role of heme oxygenase 1

    Article • Experimental Neurology, July 2010, Elsevier

    Sylvain Dore

  78. Microsomal prostaglandin E synthase-2: Cellular distribution and expression in Alzheimer's disease

    Article • Experimental Neurology, June 2010, Elsevier

    Sylvain Dore

  79. The flavanol (−)-epicatechin prevents stroke damage through the Nrf2/HO1 pathway

    Article • Journal of Cerebral Blood Flow & Metabolism, May 2010, SAGE Publications

    Sylvain Dore

  80. Prostaglandin D2 DP1 receptor is beneficial in ischemic stroke and in acute exicitotoxicity in young and old mice

    Article • AGE, March 2010, Springer Science + Business Media

    Sylvain Dore

  81. Neuroprotective effect of HT008-1, a prescription of traditional Korean medicine, on transient focal cerebral ischemia model in rats

    Article • Phytotherapy Research, February 2010, Wiley

    Sylvain Dore

  82. Serine Racemase Deletion Protects Against Cerebral Ischemia and Excitotoxicity

    Article • Journal of Neuroscience, January 2010, Society for Neuroscience

    Sylvain Dore

  83. Death-Associated Protein Kinase-Mediated Cell Death Modulated by Interaction with DANGER

    Article • Journal of Neuroscience, January 2010, Society for Neuroscience

    Sylvain Dore

  84. Importance of normothermia control in investigating delayed neuronal injury in a mouse global ischemia model

    Article • Journal of Neuroscience Methods, January 2010, Elsevier

    Sylvain Dore

  85. GOSPEL: A Neuroprotective Protein that Binds to GAPDH upon S-Nitrosylation

    Article • Neuron, September 2009, Elsevier

    Sylvain Dore

  86. Heme oxygenase 1 is associated with ischemic preconditioning-induced protection against brain ischemia

    Article • Neurobiology of Disease, August 2009, Elsevier

    Sylvain Dore

  87. Lipocalin-prostaglandin D synthase is a critical beneficial factor in transient and permanent focal cerebral ischemia

    Article • Neuroscience, April 2009, Elsevier

    Sylvain Dore

  88. Heme–Hemopexin Complex Attenuates Neuronal Cell Death and Stroke Damage

    Article • Journal of Cerebral Blood Flow & Metabolism, March 2009, SAGE Publications

    Sylvain Dore

  89. Reduced acute brain injury in PGE2 EP3 receptor-deficient mice after cerebral ischemia

    Article • Journal of Neuroimmunology, March 2009, Elsevier

    Sylvain Dore

  90. Low Doses of Carbon Monoxide Protect Against Experimental Focal Brain Ischemia

    Article • Neurotoxicity Research, February 2009, Springer Science + Business Media

    Sylvain Dore

  91. PGF2α FP Receptor Contributes to Brain Damage Following Transient Focal Brain Ischemia

    Article • Neurotoxicity Research, January 2009, Springer Science + Business Media

    Sylvain Dore

  92. Ginkgo Biloba Extract Neuroprotective Action Is Dependent on Heme Oxygenase 1 in Ischemic Reperfusion Brain Injury

    Article • Stroke, December 2008, Wolters Kluwer Health

    Sylvain Dore

  93. Selective blockade of PGE2 EP1 receptor protects brain against experimental ischemia and excitotoxicity, and hippocampal slice cultures against oxygen-glucose deprivation

    Article • Neurotoxicity Research, December 2008, Springer Science + Business Media

    Sylvain Dore

  94. Cytosolic Prostaglandin E Synthase: Expression Patterns in Control and Alzheimer's Disease Brains

    Article • American Journal of Alzheimer s Disease & Other Dementias®, November 2008, SAGE Publications

    Sylvain Dore

  95. Enhancing effect of HT008-1 on cognitive function and quality of life in cognitively declined healthy adults: A randomized, double-blind, placebo-controlled, trial

    Article • Pharmacology Biochemistry and Behavior, October 2008, Elsevier

    Sylvain Dore

  96. Prostacyclin receptor deletion aggravates hippocampal neuronal loss after bilateral common carotid artery occlusion in mouse

    Article • Neuroscience, October 2008, Elsevier

    Sylvain Dore

  97. Heme oxygenase 2 deficiency increases brain swelling and inflammation after intracerebral hemorrhage

    Article • Neuroscience, September 2008, Elsevier

    Sylvain Dore

  98. Role of heme oxygenase-2 in pial arteriolar response to acetylcholine in mice with and without transfusion of cell-free hemoglobin polymers

    Article • AJP Regulatory Integrative and Comparative Physiology, August 2008, American Physiological Society

    Sylvain Dore

  99. The development of an improved preclinical mouse model of intracerebral hemorrhage using double infusion of autologous whole blood

    Article • Brain Research, July 2008, Elsevier

    Sylvain Dore

  100. Expression and localization of prostaglandin transporter in Alzheimer disease brains and age-matched controls

    Article • Journal of Neuroimmunology, March 2008, Elsevier

    Sylvain Dore

  101. Neuroprotection and Enhancement of Spatial Memory by Herbal Mixture HT008-1 in Rat Global Brain Ischemia Model

    Article • The American Journal of Chinese Medicine, January 2008, World Scientific Pub Co Pte Lt

    Sylvain Dore

  102. Elevated microsomal prostaglandin‐E synthase‐1 in Alzheimer's disease

    Article • Alzheimer s & Dementia, December 2007, Wiley

    Sylvain Dore

  103. Optimized protocol to reduce variable outcomes for the bilateral common carotid artery occlusion model in mice

    Article • Journal of Neuroscience Methods, October 2007, Elsevier

    Sylvain Dore

  104. Role of Nrf2 in protection against intracerebral hemorrhage injury in mice

    Article • Free Radical Biology and Medicine, August 2007, Elsevier

    Sylvain Dore

  105. PGD2 DP1 receptor protects brain from ischemia-reperfusion injury

    Article • European Journal of Neuroscience, June 2007, Wiley

    Sylvain Dore

  106. Role of reactive oxygen species in modulation of Nrf2 following ischemic reperfusion injury

    Article • Neuroscience, June 2007, Elsevier

    Sylvain Dore

  107. Heme oxygenase-1 exacerbates early brain injury after intracerebral haemorrhage

    Article • Brain, April 2007, Oxford University Press (OUP)

    Sylvain Dore

  108. Stimulation of prostaglandin E2-EP3 receptors exacerbates stroke and excitotoxic injury

    Article • Journal of Neuroimmunology, March 2007, Elsevier

    Sylvain Dore

  109. Effects of EP1 receptor on cerebral blood flow in the middle cerebral artery occlusion model of stroke in mice

    Article • Journal of Neuroscience Research, January 2007, Wiley

    Sylvain Dore

  110. Stimulation of Prostaglandin EP2 Receptors Prevents NMDA-Induced Excitotoxicity

    Article • Journal of Neurotrauma, December 2006, Mary Ann Liebert Inc

    Dr Valentina Echeverria Moran, Sylvain Dore

  111. Inflammation after Intracerebral Hemorrhage

    Article • Journal of Cerebral Blood Flow & Metabolism, October 2006, SAGE Publications

    Sylvain Dore

  112. GPCR antagonists as an alternative to COX-2 inhibitors: a case for the PGE2 EP1 receptor

    Article • Trends in Pharmacological Sciences, September 2006, Elsevier

    Sylvain Dore

  113. Use of an Optimized Transient Occlusion of the Middle Cerebral Artery Protocol for the Mouse Stroke Model

    Article • Journal of Stroke and Cerebrovascular Diseases, July 2006, Elsevier

    Sylvain Dore

  114. Erratum to “Prostaglandin EP4 receptor agonist protects against acute neurotoxicity” [Brain Res. 1066 (2005) 71–77]

    Article • Brain Research, June 2006, Elsevier

    Sylvain Dore

  115. Heme oxygenase 2 is neuroprotective against intracerebral hemorrhage

    Article • Neurobiology of Disease, June 2006, Elsevier

    Sylvain Dore

  116. Dependence of acetylcholine and ADP dilation of pial arterioles on heme oxygenase after transfusion of cell-free polymeric hemoglobin

    Article • AJP Heart and Circulatory Physiology, March 2006, American Physiological Society

    Sylvain Dore

  117. 1-HydroxyPGE1reduces infarction volume in mouse transient cerebral ischemia

    Article • European Journal of Neuroscience, January 2006, Wiley

    Dr Valentina Echeverria Moran, Sylvain Dore

  118. Heme oxygenase-1 protects brain from acute excitotoxicity

    Article • Neuroscience, January 2006, Elsevier

    Sylvain Dore

  119. Prostaglandin EP4 receptor agonist protects against acute neurotoxicity

    Article • Brain Research, December 2005, Elsevier

    Sylvain Dore

  120. Stimulation of PGE2receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following β-amyloid exposure

    Article • European Journal of Neuroscience, November 2005, Wiley

    Dr Valentina Echeverria Moran, Sylvain Dore

  121. Prostaglandin EP1 Receptor Contributes to Excitotoxicity and Focal Ischemic Brain Damage

    Article • Toxicological Sciences, October 2005, Oxford University Press (OUP)

    Sylvain Dore

  122. Expression of Prostaglandin E2 Synthases in Mouse Postnatal Cortical Neurons

    Article • Annals of the New York Academy of Sciences, August 2005, Wiley

    Dr Valentina Echeverria Moran, Sylvain Dore

  123. Catalytically inactive heme oxygenase-2 mutant is cytoprotective

    Article • Free Radical Biology and Medicine, August 2005, Elsevier

    Sylvain Dore

  124. Questions and Answers: Session II: Mechanisms of Neuroprotection (1)

    Article • Annals of the New York Academy of Sciences, August 2005, Wiley

    Sylvain Dore

  125. Questions and Answers: Session IV: Role of Carnitines and Other Agents in Neuroprotection

    Article • Annals of the New York Academy of Sciences, August 2005, Wiley

    Sylvain Dore

  126. Questions and Answers: Session X: Novel Approaches to Neuroprotection

    Article • Annals of the New York Academy of Sciences, August 2005, Wiley

    Sylvain Dore

  127. Characterization of Heme Oxygenase in Adult Rodent Platelets

    Article • Current Neurovascular Research, April 2005, Bentham Science Publishers

    Sylvain Dore

  128. Stroke Outcomes in Mice Lacking the Genes for Neuronal Heme Oxygenase-2 and Nitric Oxide Synthase

    Article • Current Neurovascular Research, January 2005, Bentham Science Publishers

    Sylvain Dore

  129. Distinct protective mechanisms of HO-1 and HO-2 against hydroperoxide-induced cytotoxicity

    Article • Free Radical Biology and Medicine, January 2005, Elsevier

    Sylvain Dore

  130. Unique Properties of Polyphenol Stilbenes in the Brain: More than Direct Antioxidant Actions; Gene/Protein Regulatory Activity

    Article • Neurosignals, January 2005, Karger Publishers

    Sylvain Dore

  131. Differential roles of neuronal and endothelial nitric oxide synthases during carrageenan-induced inflammatory hyperalgesia

    Article • Neuroscience, January 2004, Elsevier

    Sylvain Dore

  132. Neuronal overexpression of cyclooxygenase-2 increases cerebral infarction

    Article • Annals of Neurology, May 2003, Wiley

    Sylvain Dore

  133. Regulation of Heme Oxygenase Expression by Cyclopentenone Prostaglandins

    Article • Experimental Biology and Medicine, May 2003, SAGE Publications

    Sylvain Dore

  134. Decreased activity of the antioxidant heme oxygenase enzyme: implications in ischemia and in Alzheimer’s disease1,2 1Guest Editors: Mark A. Smith and George Perry 2This article is part of a series of reviews on “Causes and Consequences of Oxidative Str...

    Article • Free Radical Biology and Medicine, June 2002, Elsevier

    Professor George Perry, Sylvain Dore

  135. Corrigendum to “Alteration of expression levels of neuronal nitric oxide synthase and haem oxygenase-2 messenger RNA in the hippocampi and cortices of young adult and aged cognitively unimpaired and impaired Long–Evans rats”

    Article • Neuroscience, April 2001, Elsevier

    Sylvain Dore

  136. Physiologic roles for the heme oxygenase products carbon monoxide, bilirubin and iron: links to neuroprotection in stroke and Alzheimer's disease

    Article • Clinical Neuroscience Research, January 2001, Elsevier

    Sylvain Dore

  137. Amyloid Precursor Proteins Inhibit Heme Oxygenase Activity and Augment Neurotoxicity in Alzheimer's Disease

    Article • Neuron, November 2000, Elsevier

    Sylvain Dore

  138. Alteration of expression levels of neuronal nitric oxide synthase and haem oxygenase-2 messenger RNA in the hippocampi and cortices of young adult and aged cognitively unimpaired and impaired Long–Evans rats

    Article • Neuroscience, October 2000, Elsevier

    Sylvain Dore

  139. Heme oxygenase-2 acts to prevent neuronal death in brain cultures and following transient cerebral ischemia

    Article • Neuroscience, August 2000, Elsevier

    Sylvain Dore

  140. The ginkgo biloba extract (EGb 761) protects hippocampal neurons against cell death induced by β-amyloid

    Article • European Journal of Neuroscience, June 2000, Wiley

    Sylvain Dore

  141. Rediscovering good old friend IGF-I in the new millenium: possible usefulness in Alzheimer's disease and stroke

    Article • Pharmaceutica Acta Helvetiae, March 2000, Elsevier

    Sylvain Dore

  142. Rediscovering good old friend IGF-I in the new millenium: possible usefulness in Alzheimer's disease and stroke

    Article • January 2000, Elsevier

    Sylvain Dore

  143. Neuroprotective Action of Bilirubin against Oxidative Stress in Primary Hippocampal Cultures

    Article • Annals of the New York Academy of Sciences, December 1999, Wiley

    Sylvain Dore

  144. Protective and Rescuing Abilities of IGF-I and Some Putative Free Radical Scavengers against beta-Amyloid-Inducing Toxicity in Neurons

    Article • Annals of the New York Academy of Sciences, December 1999, Wiley

    Sylvain Dore

  145. Impact of neonatal kainate treatment on hippocampal insulin-like growth factor receptors

    Article • Neuroscience, July 1999, Elsevier

    Sylvain Dore

  146. Haem oxygenase-1 prevents cell death by regulating cellular iron

    Article • Nature Cell Biology, June 1999, Springer Science + Business Media

    Sylvain Dore

  147. Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury

    Article • Proceedings of the National Academy of Sciences, March 1999, Proceedings of the National Academy of Sciences

    Sylvain Dore

  148. Insulin-like growth factors-I and -II differentially regulate endogenous acetylcholine release from the rat hippocampal formation

    Article • Proceedings of the National Academy of Sciences, December 1997, Proceedings of the National Academy of Sciences

    Sylvain Dore

  149. Distribution and levels of [125I]IGF-I, [125I]IGF-II and [125I]insulin receptor binding sites in the hippocampus of aged memory-unimpaired and -impaired rats

    Article • Neuroscience, August 1997, Elsevier

    Sylvain Dore

  150. Discussion

    Article • Trends in Neurosciences, August 1997, Elsevier

    Sylvain Dore

  151. Systemic administration of kainic acid induces selective time dependent decrease in [125I]insulin-like growth factor I, [125I]insulin-like growth factor II and [125I]insulin receptor binding sites in adult rat hippocampal formation

    Article • Neuroscience, August 1997, Elsevier

    Sylvain Dore

  152. Insulin-like growth factor I protects and rescues hippocampal neurons against β-amyloid- and human amylin-induced toxicity

    Article • Proceedings of the National Academy of Sciences, April 1997, Proceedings of the National Academy of Sciences

    Sylvain Dore

  153. Presence and differential internalization of two distinct insulin-like growth factor receptors in rat hippocampal neurons

    Article • Neuroscience, March 1997, Elsevier

    Sylvain Dore

  154. IGF and IGF-binding protein system in the synovial fluid of osteoarthritic and rheumatoid arthritic patients

    Article • Osteoarthritis and Cartilage, December 1996, Elsevier

    Sylvain Dore

  155. Prostaglandin E2 stimulates incorporation of proline into collagenase digestible proteins in human articular chondrocytes: identification of an effector autocrine loop involving insulin-like growth factor I

    Article • Molecular and Cellular Endocrinology, October 1996, Elsevier

    Sylvain Dore

  156. Distribution and levels of insulin-like growth factor (IGF-I and IGF-II) and insulin receptor binding sites in the spinal cords of amyotrophic lateral sclerosis (ALS) patients

    Article • Molecular Brain Research, September 1996, Elsevier

    Sylvain Dore

  157. Increased insulin-like growth factor 1 production by human osteoarthritic chondrocytes is not dependent on growth hormone action

    Article • Arthritis & Rheumatism, March 1995, Wiley

    Sylvain Dore

  158. Effects of exercise during normoxia and hypoxia on the growth hormone?insulin-like growth factor I axis

    Article • European Journal of Applied Physiology and Occupational Physiology, January 1995, Springer Science + Business Media

    Sylvain Dore

  159. Human Osteoarthritic Chondrocytes Possess an Increased Number of Insulin-Like Growth Factor 1 Binding Sites but are Unresponsive to its Stimulation

    Article • Arthritis & Rheumatism, February 1994, Wiley

    Sylvain Dore

  160. Contribution of hGH20K variant to blood hGH response in sauna and exercise

    Article • European Journal of Applied Physiology and Occupational Physiology, January 1991, Springer Science + Business Media

    Sylvain Dore